fbpx

Sonic Healthcare – Buy

SHL:ASX is under Algo Engine buy conditions and is a current holding in our ASX model portfolio.

FY22 revenue is likely to be around $7.6bn on EBITDA of $1.7bn. EPS growth will moderate to 5 – 10%, which will continue to support a forward yield of 3.5%.

You're not a member!  Trial today

Investor Signals Pty Ltd ABN 44 143 555 453 is a Corporate Authorised Representative CAR No. 439411 of Advisor Plus Pty Ltd AFSL 474520
© 2024 Investor Signals

Send our ASX Research to your Inbox

Or start a free thirty day trial for our full service, which includes our ASX Research.